SCHEMBL18398366

SCHEMBL18398366

CCc1cc(F)ccc1Oc1cc2c(ncn2C)c(N)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.36
▸ BRD4 O60885 6/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ SLC22A12 Q96S37 1/20 0.35
▸ BRD2 P25440 3/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ CTSS P25774 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ SLC6A4 P31645 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ P2RX2 Q9UBL9 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409147 0.84 JAK2 (0.39) CTSSCTSKJAK2JAK1TYK2
SCHEMBL18398450 0.77 KDM4E (0.38) SLC22A12SLC6A4HTR2AKCNH2
SCHEMBL18409184 0.76 JAK2 (0.36) LMNABRD4SLC22A12JAK2JAK1
SCHEMBL18398296 0.76 JAK2 (0.37) LMNAIKBKBJAK2JAK1TYK2
SCHEMBL18398531 0.75 LMNA (0.36) LMNAIKBKBKCNH2TLR7
SCHEMBL18409427 0.74 JAK2 (0.34) JAK2JAK1TYK2JAK3
SCHEMBL18398421 0.69 JAK2 (0.35) LMNAIKBKBJAK2JAK1TYK2
SCHEMBL15457576 0.68 AHCY (0.49) LMNAIKBKBCTSSCTSK
SCHEMBL18398609 0.67 TLR7 (0.32) LMNAJAK2JAK1TYK2JAK3
SCHEMBL18409444 0.66 JAK2 (0.40) IKBKBJAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback